Show notes
“To us, it’s exactly the opposite of a marketing slogan. If we make a decision that has a negative impact on a patient, we’ve made a bad decision,” says Stuart Needleman.
Stuart Needleman is Chief Commercial Officer and Chief Patient Centricity Officer at Piramal Pharma Solutions. Before Piramal, he was President of Laurus Synthesis and President and COO of Aptuit, and he held earlier roles at Cambrex, Oxford Asymmetry, ChiRex, and Rhodia Pharma Solutions. He has spent 46 years in the CDMO industry and joined Piramal about a decade ago.
In the latest PharmaSource podcast episode, recorded at…
Website: podcasters.spotify.com

